Date Filed | Type | Description |
09/27/2023 |
425
| Form 425 - Prospectuses and communications, business combinations: |
09/27/2023 |
8-K
| Quarterly results |
08/21/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
08/07/2023 |
SC 13D/A
| Rafael Holdings, Inc. reports a 49% stake in Cyclo Therapeutics, Inc. |
08/03/2023 |
8-K
| Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits Interactive Data |
07/31/2023 |
8-K
| Quarterly results |
06/02/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
05/18/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and... |
05/12/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
05/11/2023 |
SC 13D
| Rafael Holdings, Inc. reports a 16.6% stake in Cyclo Therapeutics, Inc. |
05/04/2023 |
8-K
| Quarterly results |
05/01/2023 |
10-K/A
| Annual Report for the period ended December 31, 2022 [amend] |
04/24/2023 |
8-K
| Quarterly results |
03/21/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
03/20/2023 |
8-K
| Quarterly results |
03/17/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
03/08/2023 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders... |
02/14/2023 |
SC 13G/A
| ARMISTICE CAPITAL, LLC reports a 10.8% stake in CYCLO THERAPEUTICS, INC. |
02/14/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
02/10/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/10/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
01/31/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
01/27/2023 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
01/20/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
01/03/2023 |
8-K
| Quarterly results |
01/03/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
11/23/2022 |
RW
| Form RW - Registration Withdrawal Request: |
11/21/2022 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
11/10/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
10/31/2022 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
08/15/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
06/24/2022 |
8-K
| Quarterly results |
05/12/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
|